<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39461945</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2158-3188</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Translational psychiatry</Title><ISOAbbreviation>Transl Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Memory complaints after COVID-19: a potential indicator of primary cognitive impairment or a correlate of psychiatric symptoms?</ArticleTitle><Pagination><StartPage>455</StartPage><MedlinePgn>455</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">455</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41398-024-03154-w</ELocationID><Abstract><AbstractText>Cognitive impairment and symptoms of psychiatric disorders have been reported frequently as features of post-acute sequelae of SARS-CoV-2 infection. This study aims to investigate subjective memory complaints in COVID-19 survivors and determine if these are more strongly associated with objective cognitive impairment related to sequelae of SARS-CoV-2 infection or with symptoms of psychiatric conditions. A total of 608 COVID-19 survivors were evaluated in-person 6-11 months after hospitalization, with 377 patients assigned to a "no subjective memory complaint (SMC)" group and 231 patients assigned to an SMC group based on their Memory Complaint Scale scores. Follow-up evaluations included an objective cognitive battery and scale-based assessments of anxiety, depression, and post-traumatic stress symptoms. We found the perception of memory impairment in COVID-19 survivors to be more strongly associated to core symptoms of psychiatric conditions rather than to primary objective cognitive impairment. Univariate analysis indicated significant differences between the "no SMC" and SMC groups, both for the psychiatric symptom evaluations and for the cognitive evaluations (p &lt; 0.05); however, the psychiatric symptoms all had large partial eta-squared values (ranging from 0.181 to 0.213), whereas the cognitive variables had small/medium partial eta-squared values (ranging from 0.002 to 0.024). Additionally, multiple regression analysis indicated that only female sex and depressive and post-traumatic stress symptoms were predictors of subjective memory complaints. These findings may help guide clinical evaluations for COVID-19 survivors presenting with memory complaints while also serving to expand our growing understanding of the relationship between COVID-19, subjective memory complaints, and the risk of cognitive decline.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yiling</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5858-5767</Identifier><AffiliationInfo><Affiliation>The George Washington School of Medicine and Health Sciences, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritto</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Departamento de Fisioterapia, Fonoaudiologia e Terapia Ocupacional, Faculdade de Medicina FMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damiano</LastName><ForeName>Rodolfo Furlan</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coli</LastName><ForeName>Amanda Goulart</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadade</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Cristiana Castanho de Almeida</ForeName><Initials>CCA</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serafim</LastName><ForeName>Antonio de Pádua</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guedes</LastName><ForeName>Bruno Fukelmann</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitrini</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imamura</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departamento de Medicina Legal, Bioética, Medicina do Trabalho e Medicina Física e Reabilitação, Faculdade de Medicina FMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlenza</LastName><ForeName>Orestes Vicente</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busatto Filho</LastName><ForeName>Geraldo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4749-4602</Identifier><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil. geraldo.busatto@hc.fm.usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Psychiatry</MedlineTA><NlmUniqueID>101562664</NlmUniqueID><ISSNLinking>2158-3188</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="Y">Memory Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013313" MajorTopicYN="Y">Stress Disorders, Post-Traumatic</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>7</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39461945</ArticleId><ArticleId IdType="pmc">PMC11513141</ArticleId><ArticleId IdType="doi">10.1038/s41398-024-03154-w</ArticleId><ArticleId IdType="pii">10.1038/s41398-024-03154-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023;29:2347–57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, Kim SW. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci Rep. 2023;13:11207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-Júnior JWL, de Souza ACC, Borges JWP, Oliveira DN, Siqueira-Neto JI, Sobreira-Neto MA, et al. COVID-19 associated cognitive impairment: a systematic review. Cortex. 2022;152:77–97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Caruso MJG, Cincoto AV, de Almeida Rocca CC, de Pádua Serafim A, Bacchi P, et al. Post-COVID-19 psychiatric and cognitive morbidity: preliminary findings from a Brazilian cohort study. Gen Hosp Psychiatry. 2022;75:38–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734055</ArticleId><ArticleId IdType="pubmed">35134702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonçalves NG, Aliberti MJR, Bertola L, Avelino-Silva T, Dias MB, Apolinario D, et al. Dissipating the fog: cognitive trajectories and risk factors 1 year after COVID-19 hospitalization. Alzheimers Dement. 2023;19:3771–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">36861807</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman S, Green K, Lane TE. COVID-19 and the impact on Alzheimer's disease pathology. J Neurochem. 2024;168:3415–3429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11024062</ArticleId><ArticleId IdType="pubmed">37850241</ArticleId></ArticleIdList></Reference><Reference><Citation>Botto R, Callai N, Cermelli A, Causarano L, Rainero I. Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline. Neurol Sci. 2022;43:4107–24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9213384</ArticleId><ArticleId IdType="pubmed">35461471</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF. The relationship between anxiety and Alzheimer’s Disease. J Alzheimers Dis Rep. 2021;5:171–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075566</ArticleId><ArticleId IdType="pubmed">33981954</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmand B, Jonker C, Geerlings MI, Lindeboom J. Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry. 1997;171:373–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9373429</ArticleId></ArticleIdList></Reference><Reference><Citation>Vale FAC, Balieiro AP, Silva-Filho JH. Memory complaint scale (MCS). Proposed tool for active systematic search. Dement Neuropsychol. 2012;6:212–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619332</ArticleId><ArticleId IdType="pubmed">29213800</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren SL, Reid E, Whitfield P, Moustafa AA. Subjective memory complaints as a predictor of mild cognitive impairment and Alzheimer’s disease. Discover Psychology. 2022;2:13.</Citation></Reference><Reference><Citation>Warren SL, Reid E, Whitfield P, Helal AM, Abo H, Tindle R, et al. Cognitive and behavioral abnormalities in individuals with Alzheimer’s disease, mild cognitive impairment and subjective memory complaints. Curr Psychol. 2024;43:800–810.</Citation></Reference><Reference><Citation>Elfgren C, Gustafson L, Vestberg S, Passant U. Subjective memory complaints, neuropsychological performance and psychiatric variables in memory clinic attendees: a 3-year follow-up study. Arch Gerontol Geriatr. 2010;51:e110–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20211500</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates JA, Clare L, Woods RT. CFAS M. Subjective memory complaints, mood and MCI: a follow-up study. Aging Ment Health. 2017;21:313–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5351791</ArticleId><ArticleId IdType="pubmed">26329364</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster-Cordero F, Giménez-Llort L. The Challenge of Subjective Cognitive Complaints and Executive Functions in Middle-Aged Adults as a Preclinical Stage of Dementia: A Systematic Review. Geriatrics. 2022;7:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938842</ArticleId><ArticleId IdType="pubmed">35314602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell TR, Beck A, Gillespie NA, Reynolds CA, Elman JA, Williams ME, et al. A traitlike dimension of subjective memory concern over 30 years among adult male twins. JAMA Psychiatry. 2023;80:718–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10173101</ArticleId><ArticleId IdType="pubmed">37163244</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrie RA, Cohen J, Stuve O, Trojano M, Sørensen PS, Reingold S, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21:263–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4361468</ArticleId><ArticleId IdType="pubmed">25623244</ArticleId></ArticleIdList></Reference><Reference><Citation>Margoni M, Preziosa P, Rocca MA, Filippi M. Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Transl Psychiatry. 2023;13:264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10356956</ArticleId><ArticleId IdType="pubmed">37468462</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JR, Fitzgerald KC, Murrough JW, Katz Sand IB, Sorets TR, Krieger SC, et al. Depression symptoms and cognition in multiple sclerosis: Longitudinal evidence of a specific link to executive control. Mult Scler. 2023;29:1632–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">37772495</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E, et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017;264:1715–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5533849</ArticleId><ArticleId IdType="pubmed">28567537</ArticleId></ArticleIdList></Reference><Reference><Citation>Rourke SB, Halman MH, Bassel C. Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. J Clin Exp Neuropsychol. 1999;21:737–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10649531</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique LA, Brew BJ. Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection. Handb Clin Neurol. 2019;165:71–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">31727231</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyne JD, Brickman AM. The impact of the COVID-19 pandemic on dementia risk: potential pathways to cognitive decline. Neurodegener Dis. 2021;21:1–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8678181</ArticleId><ArticleId IdType="pubmed">34348321</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy-González M, Navarra-Ventura G, Gomà G, de Haro C, Espinal C, Fortià C, et al. Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors. Crit Care. 2023;27:188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10184095</ArticleId><ArticleId IdType="pubmed">37189173</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Sánchez C, Calabria M, Grunden N, Pons C, Arroyo JA, Gómez-Anson B, et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12:e2508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando SJ, Dornbush R, Lynch S, Shahar S, Klepacz L, Karmen CL, et al. Neuropsychological, medical, and psychiatric findings after recovery from acute COVID-19: a cross-sectional study. J Acad Consult Liaison Psychiatry. 2022;63:474–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786396</ArticleId><ArticleId IdType="pubmed">35085824</ArticleId></ArticleIdList></Reference><Reference><Citation>Feter N, Caputo EL, Leite JS, Delpino FM, Cassuriaga J, da Silva CN, et al. Incidence of memory complaints during the COVID-19 pandemic in Southern Brazil: findings from PAMPA cohort. Dement Neuropsychol. 2023;17:e20220072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10202330</ArticleId><ArticleId IdType="pubmed">37223842</ArticleId></ArticleIdList></Reference><Reference><Citation>Muschel C, Lynch ST, Dornbush R, Klepacz L, Shahar S, Ferrando SJ. Frequency, Characteristics, and Correlates of Cognitive Complaints in a Cohort of Individuals with Post-Acute Sequelae of COVID-19. Brain Sci. 2023;14:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10813274</ArticleId><ArticleId IdType="pubmed">38275508</ArticleId></ArticleIdList></Reference><Reference><Citation>Miethke-Morais A, Perondi B, Harima L, Montal AC, Baldassare RM, Moraes DP, et al. Overcoming barriers to providing comprehensive inpatient care during the COVID-19 pandemic. Clinics (Sao Paulo). 2020;75:e2100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314577</ArticleId><ArticleId IdType="pubmed">32609227</ArticleId></ArticleIdList></Reference><Reference><Citation>Perondi B, Miethke-Morais A, Montal AC, Harima L, Segurado AC. Committee HdCC-CM. Setting up hospital care provision to patients with COVID-19: lessons learnt at a 2400-bed academic tertiary center in São Paulo, Brazil. Braz J Infect Dis. 2020;24:570–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604059</ArticleId><ArticleId IdType="pubmed">33157034</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020;370:m2516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327913</ArticleId><ArticleId IdType="pubmed">32611558</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, de Araújo AL, Duarte AJDS, Levin AS, Guedes BF, Kallas EG, et al. Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil. BMJ Open. 2021;11:e051706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249176</ArticleId><ArticleId IdType="pubmed">34193506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira JC, Moreira TCL, de Araújo AL, Imamura M, Damiano RF, Garcia ML, et al. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. J Glob Health. 2022;12:05029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9359428</ArticleId><ArticleId IdType="pubmed">35939273</ArticleId></ArticleIdList></Reference><Reference><Citation>Roffman CE, Buchanan J, Allison GT. Charlson comorbidities index. J Physiother. 2016;62:171.</Citation><ArticleIdList><ArticleId IdType="pubmed">27298055</ArticleId></ArticleIdList></Reference><Reference><Citation>infection WWGotCCaMoC-. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda AR, Scotta AV, Cortez MV, Soria EA. Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors. Midwifery. 2021;102:103072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437687</ArticleId><ArticleId IdType="pubmed">34218023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang EH, Kim KH. Effects of cognition, daily-living stress, and health-promotion behavior on subjective memory complaints by community-dwelling elders. J Korean Gerontol Nurs. 2019;21:135–43.</Citation></Reference><Reference><Citation>Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr. 2001;59:532–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11588630</ArticleId></ArticleIdList></Reference><Reference><Citation>AIT- Army Individual Test Battery. Manual of directions and scoring. 1944. Washington, DC: War Department, Adjutant General's Office.</Citation></Reference><Reference><Citation>Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol. 1991;48:278–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">2001185</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer’s disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer’s Disease. Arch Neurol. 1992;49:448–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">1580805</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard BA, Goldman JG. MMSE - Mini-Mental State Examination. In Encyclopedia of Movement Disorders. Elsevier Inc. 2010. pp. 187–189.</Citation></Reference><Reference><Citation>(ABEP) ABdEdP. Critério de Classificação Econômica no Brasil São Paulo, SP: Associação Brasileira de Empresas de Pesquisa; 2020. https://www.abep.org/criterio-brasil.</Citation></Reference><Reference><Citation>(IBGE) IBdGeE. Desigualdades sociais por raça ou cor no Brasil: notas técnicas. Rio de Janeiro, RJ: IBGE; 2019.</Citation></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56:2001494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistella LR, Imamura M, De Pretto LR, Van Cauwenbergh SKHA, Delgado Ramos V, Saemy Tome Uchiyama S, et al. Long-term functioning status of COVID-19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalisation. BMJ Open. 2022;12:e057246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9334693</ArticleId><ArticleId IdType="pubmed">35896292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann N, Cardoso CO, Kristensen CH, Fonseca RP. Brazilian norms and effects of age and education on the Hayling and Trail Making Tests. Trends Psychiatry Psychother. 2017;39:188–95.</Citation><ArticleIdList><ArticleId IdType="pubmed">28977074</ArticleId></ArticleIdList></Reference><Reference><Citation>Brucki SM, Malheiros SM, Okamoto IH, Bertolucci PH. [Normative data on the verbal fluency test in the animal category in our milieu]. Arq Neuropsiquiatr. 1997;55:56–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">9332561</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114:428–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlaja RE, Kauhanen LS, Ollila HS, Tuulio-Henriksson AS, Koskinen SK, Tiainen M, et al. Associations of subjective and objective cognitive functioning after COVID-19: a six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health. 2023;27:100587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812472</ArticleId><ArticleId IdType="pubmed">36624888</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjone KS, Stubberud J, Buanes EA, Hagen M, Laake JH, Hofsø K. Objective and subjective cognitive status after intensive care unit treatment for COVID-19. Brain Behav Immun Health. 2024;38:100786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11103414</ArticleId><ArticleId IdType="pubmed">38770194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant VE, Fieo RA, Fiore AJ, Richards VL, Porges EC, Williams R, et al. Subjective cognitive complaints: predictors and health outcomes in people living with HIV. AIDS Behav. 2022;26:1163–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938306</ArticleId><ArticleId IdType="pubmed">34550502</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. Long COVID syndrome-associated brain fog. J Med Virol. 2022;94:979–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Rocca CCA, Serafim AP, Loftis JM, Talib LL, Pan PM, et al. Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers. Front Immunol. 2023;14:1174020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242059</ArticleId><ArticleId IdType="pubmed">37287969</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with Post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews SB, Arnold SE, Epperson CN. Hospitalization and cognitive decline: can the nature of the relationship be deciphered? Am J Geriatr Psychiatry. 2014;22:465–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4080837</ArticleId><ArticleId IdType="pubmed">23567430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa NMF, Maranhão ACPF, Braga LW. Cognitive impairment and neuropsychiatric symptoms among individuals with history of symptomatic SARS-CoV-2 infection: a retrospective longitudinal study. Dement Neuropsychol. 2024;18:e20230053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10901560</ArticleId><ArticleId IdType="pubmed">38425703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarty T, Hadjipavlou G, Lam RW. Cognitive dysfunction in major depressive disorder: assessment, impact, and management. Focus (Am Psychiatr Publ). 2016;14:194–206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6519654</ArticleId><ArticleId IdType="pubmed">31975803</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi SU, Long ME, Bradshaw MR, Pyne JM, Magruder KM, Kimbrell T, et al. Does PTSD impair cognition beyond the effect of trauma? J Neuropsychiatry Clin Neurosci. 2011;23:16–28.</Citation><ArticleIdList><ArticleId IdType="pubmed">21304135</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts AL, Liu J, Lawn RB, Jha SC, Sumner JA, Kang JH, et al. Association of posttraumatic stress disorder with accelerated cognitive decline in middle-aged women. JAMA Netw Open. 2022;5:e2217698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9247738</ArticleId><ArticleId IdType="pubmed">35771577</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Gutiérrez MS, Navarrete F, Sala F, Gasparyan A, Austrich-Olivares A, Manzanares J. Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. Front Psychiatry. 2020;11:432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243207</ArticleId><ArticleId IdType="pubmed">32499729</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, Tomic S, et al. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. J Alzheimers Dis. 2021;82:883–98.</Citation><ArticleIdList><ArticleId IdType="pubmed">34092646</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy JR, Peach RK, Strand EA. Progressive apraxia of speech as a sign of motor neuron disease. Am J Speech Lang Pathol. 2007;16:198–208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17666546</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>